Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Page 1
Long-term outcome in new onset refractory status epilepticus: a retrospective study.
Stretti F, Bögli SY, Casagrande F, Eisele A, Galovic M, Keller E, Brandi G. Stretti F, et al. Among authors: brandi g. Crit Care. 2024 Mar 12;28(1):72. doi: 10.1186/s13054-024-04858-7. Crit Care. 2024. PMID: 38475798 Free PMC article.
This retrospective study investigates ICU treatments, short- and long-term outcome and ethical decisions of a case series of patients with NORSE. ...The functional outcome improved over time for 13/16 (81%) hospital survivors (median mRS at hospital discharge 4 [3.75-5] vs …
This retrospective study investigates ICU treatments, short- and long-term outcome and ethical decisions of a case series of patients …
Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?
Laurenzi A, Brandi G, Greco F, Prosperi E, Palloni A, Serenari M, Frega G, Ravaioli M, Rizzo A, Cescon M. Laurenzi A, et al. Among authors: brandi g. Langenbecks Arch Surg. 2023 Feb 24;408(1):102. doi: 10.1007/s00423-023-02839-y. Langenbecks Arch Surg. 2023. PMID: 36826620
In recent years, some reports have been published on repeated resection suggesting a survival benefit. The aim of this study was to evaluate the long-term outcome of all repeated resections for recurrent CCA in our institution. ...
In recent years, some reports have been published on repeated resection suggesting a survival benefit. The aim of this study was to evaluate …
Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-Analysis.
Rizzo A, Ricci AD, Fanizzi A, Massafra R, De Luca R, Brandi G. Rizzo A, et al. Among authors: brandi g. Curr Oncol. 2023 Jan 5;30(1):749-757. doi: 10.3390/curroncol30010057. Curr Oncol. 2023. PMID: 36661706 Free PMC article. Review.
The CR rate observed in HCC patients receiving immune-based combinations appears more than twelve times higher compared with sorafenib monotherapy, supporting the long-term benefit of these combinatorial strategies, with even the possibility to cure advanced disease....
The CR rate observed in HCC patients receiving immune-based combinations appears more than twelve times higher compared with sorafenib monot …
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.
Rimini M, Casadei-Gardini A, Brandi G, Leone F, Fornaro L, Pella N, Silvestris N, Montagnani F, Lonardi S, Lai E, Galizia E, Santini D, Palloni A, Filippi R, Masi G, Aprile G, Aglietta M, Frega G, Fenocchio E, Vivaldi C, Satolli MA, Salani F, Scartozzi M, Faloppi L, Pellino A, Sperti E, Burgio V, Ratti F, Aldrighetti L, Cascinu S, Cucchetti A. Rimini M, et al. Among authors: brandi g. J Chemother. 2022 Dec;34(8):543-549. doi: 10.1080/1120009X.2022.2036557. Epub 2022 Feb 14. J Chemother. 2022. PMID: 35156913
Heterogenicity between hospital did not affect the outcome in term of overall survival....
Heterogenicity between hospital did not affect the outcome in term of overall survival....
Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series.
Keller E, Brandi G, Winklhofer S, Imbach LL, Kirschenbaum D, Frontzek K, Steiger P, Dietler S, Haeberlin M, Willms J, Porta F, Waeckerlin A, Huber M, Abela IA, Lutterotti A, Stippich C, Globas C, Varga Z, Jelcic I. Keller E, et al. Among authors: brandi g. Stroke. 2020 Dec;51(12):3719-3722. doi: 10.1161/STROKEAHA.120.031224. Epub 2020 Oct 15. Stroke. 2020. PMID: 33054673 Free PMC article.
Central nervous system disorders associated with COVID-19 may lead to long-term disabilities. Mechanisms should be urgently investigated to develop neuroprotective strategies....
Central nervous system disorders associated with COVID-19 may lead to long-term disabilities. Mechanisms should be urgently investiga …
Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives.
Rizzo A, Ricci AD, Tavolari S, Brandi G. Rizzo A, et al. Among authors: brandi g. Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):441-452. doi: 10.21873/cgp.20203. Cancer Genomics Proteomics. 2020. PMID: 32859625 Free PMC article. Review.
Peripheral blood of cancer patients "physiologically" presents cells and cellular components deriving from primary or metastatic sites, including circulating tumor cells (CTCs), circulating free DNA (cfDNA) and exosomes containing proteins, lipids and nucleic acids. The term
Peripheral blood of cancer patients "physiologically" presents cells and cellular components deriving from primary or metastatic sites, incl …
Use of hormones in doping and cancer risk.
De Santi M, Baldelli G, Brandi G; GSMS-SItI, Working Group on Movement Sciences for Health, Italian Society of Hygiene preventive Medicine and Public Health; WDPP, Working Group Doping Prevention Project. De Santi M, et al. Among authors: brandi g. Ann Ig. 2019 Nov-Dec;31(6):590-594. doi: 10.7416/ai.2019.2319. Ann Ig. 2019. PMID: 31616903 Free article.
Results from pre-clinical studies and epidemiological observations in patients with an excess of GH and IGF-1 production or treated with these hormones showed a positive association with the risk to develop several types of cancer. In conclusion, athletes should be made aware tha …
Results from pre-clinical studies and epidemiological observations in patients with an excess of GH and IGF-1 production or treated with the …
25 results